Harrow, Inc. Payments to Acquire Other Property, Plant, and Equipment
Harrow, Inc. (HROW) reported Payments to Acquire Other Property, Plant, and Equipment of -$524.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment · last filed 2017-03-21
- Harrow, Inc. payments to acquire other property, plant, and equipment for fiscal 2015 was -$524.00K.
| Period end | Payments to Acquire Other Property, Plant, and Equipment 12 month |
|---|---|
| 2015-12-31 | -$524.00K 10-K · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |